HyperBranch Medical Technology

About:

HyperBranch Medical Technology develops and commercializes products for the traumatic or surgically-induced wound market.

Website: http://hyperbranch.com

Top Investors: H.I.G. Capital, The Aurora Funds

Description:

HyperBranch Medical Technology, Inc., a medical device company, develops and markets products primarily for the traumatic or surgically induced wound market. It offers OcuSeal, a liquid ocular bandage for direct application on the surface of the eye to form an ocular bandage, thereby covering an opening in the eye and providing an immediate protective barrier; and Adherus Dural Sealant, which is used as an aid in dural repair in cranial and spinal surgeries, such as the treatment of intracranial aneurysms, tumors, and spinal disc disease. The company also provides Adherus Hernia Mesh Fixation, a device used as a replacement for tacks, staples, sutures, and 'O' rings in hernia repair procedur...

Total Funding Amount:

$18.6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)hyperbranch.com

Founders:

Anthony J. Sherbondy, Mark W. Grinstaff

Number of Employees:

11-50

Last Funding Date:

2013-12-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai